Alexion to Pick Goldman to Advise on Roche Offer?

July 30 (Bloomberg) -- Alexion Pharmaceuticals, the drugmaker whose blood-disease treatment is among the world’s most expensive medicines, engaged Goldman Sachs as an adviser as it prepares for a possible takeover offer from Roche, said people with knowledge of the matter. Cristina Alesci reports on Bloomberg Television's "Money Moves." (Source: Bloomberg)

Stock Selloff: What'd You Miss? (Full Show 02/08)
09:35 - Full episode of "What'd You Miss?" Guests: Russ Koesterich, BlackRock's global chief investment strategist, Peter Tchir, Brean Capital's head of macro strategy, Paul McNamara, GAM fund manager, and James Sweeney, chief economist at Credit Suisse. (Source: Bloomberg)
  • Why Canadian Miners Look Attractive to Global Buyers
  • Canadian Non-Bank Financials Are Our Biggest Short: Lloyd
  • JPMorgan: Gold Rally Breaks the Bullion Downtrend